Fig. 8From: Empagliflozin targets Mfn1 and Opa1 to attenuate microglia-mediated neuroinflammation in retinal ischemia and reperfusion injuryHypothesized schematic presentation of the protective mechanism of EMPA against retinal IR injuryBack to article page